Država: Španija
Jezik: angleščina
Source: HMA (Heads of Medicines Agencies)
toxoplasma gondii 5 log10
Intervet Intenational BV
QI04AN01
Powder and solvent for suspension for injection
Toxoplasma vaccine
Sheep
2010-10-09
Ovilis Toxovax Renew al – Product literature (FR/V/0119/001/R/002) day 90 final _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ SUMMARY OF PRODUCT CHARACTERISTICS Ovilis Toxovax Renew al – Product literature (FR/V/0119/001/R/002) day 90 final 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ovilis Toxovax 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: 10 5 live _Toxoplasma gondii_ tachyzoϊtes strain S48 per dose. EXCIPIENTS: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Concentrate and diluent for suspension for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunization of non pregnant ewes of at least 4 months old, to reduce abortion and perinatal lamb mortality caused by _Toxoplasma gondii_. 4.3 CONTRAINDICATIONS Do not vaccinate animals in the 3 weeks before mating. Do not vaccinate pregnant animals. 4.4 SPECIAL WARNINGS None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Only healthy animals should be vaccinated. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Operators should preferably wear gloves and protect their faces by a mask. Ovilis Toxovax Renew al – Product literature (FR/V/0119/001/R/002) day 90 final The product should not be handled by pregnant women as the vaccine may interfere with normal foetal development and should not be handled by persons who are immuno-deficient (e.q. AIDS sufferers; persons undergoing chemotherapy or taking immuno-suppressive drugs). Living tachyzoϊtes can cause disease Preberite celoten dokument